What is Bioventus's EV / EBITDA?

Bioventus (BVS) reported EV / EBITDA of 8.4× in Q1 2026.

How has Bioventus's EV / EBITDA changed year-over-year?

Bioventus's EV / EBITDA decreased by 84.5% year-over-year, from 53.8× to 8.4×.

What does EV / EBITDA mean?

Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

Bioventus BVS EV / EBITDA

EV / EBITDA at other companies

StrykerSYK

22.1×-11.8×

Zimmer Biomet HoldingsZBH

10.8×-1.4×

MedtronicMDT

13.9×-1.5×

ArtivionAORT

32.2×-2.2×

Globus MedicalGMED

13.8×-4.9×

Avanos MedicalAVNS

15.3×-4.6×

Other financials

Income statement

See full

Revenue$132.1M+6.6%

Gross profit$90.8M+9.3%

Operating income$8.4M+72.8%

Net income$3.1M+218%

EPS (diluted)$0.04+200%

Balance sheet

See full

Cash & equivalents$35.8M+57.2%

Total debt$288.4M-21.2%

Total equity$188.9M+27.5%

Total assets$650.5M-5.9%

Cash flow

See full

Operating cash flow$8.9M+146%

CapEx$574.0K-30.5%

Free cash flow$8.4M+141%

Valuation

See full

Market cap$659.19M+51.7%

Enterprise value$911.76M+17.2%

P/E23.1×—

P/S1.1×+0.4×

Profitability

See full

Gross margin68.7%+1.2pp

Operating margin10%—

Net margin4.9%+3.2pp

FCF margin17.5%+13.2pp

Returns & leverage

See full

Return on equity16.9%+10.9pp

Debt / equity1.5×-0.9×

Current ratio1.7×+0.3×

Where this comes from

Calculated from Bioventus’s reported figures.

enterprise value/ebitda=8.4×

Based on the most recent quarter.

The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bioventus's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bioventus's EV / EBITDA?: Bioventus (BVS) reported EV / EBITDA of 8.4× in Q1 2026.
How has Bioventus's EV / EBITDA changed year-over-year?: Bioventus's EV / EBITDA decreased by 84.5% year-over-year, from 53.8× to 8.4×.
What does EV / EBITDA mean?: Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.